A Glimpse Into The Expert Outlook On Enanta Pharma Through 4 Analysts
A Glimpse Into The Expert Outlook On Enanta Pharma Through 4 Analysts
四位分析師對恩安特製藥的專業展望
Decoding Analyst Ratings: A...4 analysts have shared their evaluations of Enanta Pharma (NASDAQ:ENTA) during the recent three months, expressing a mix of bullish and bearish perspectives.
在最近三個月內，有4位分析師對Enanta Pharma (納斯達克:ENTA) 進行了評估，表達了看好和看淡的不同觀點。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析師最近的評級概述，爲了全面了解過去30天的情緒變化並與前幾個月進行比較，提供了深入的見解。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $20.25, along with a high estimate of $27.00 and a low estimate of $10.00. A decline of 1.22% from the prior average price target is evident in the current average.
分析師提供更深入的見解，已確定了12個月的價格目標，顯示平均目標爲20.25美元，最高估價爲27.00美元，最低估價爲10.00美元。從先前的平均價格目標來看，當前的平均價格目標下降了1.22%。
Decoding Analyst Ratings: A...
分析師評...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間